Commentary: FGF21 holds promises for treating obesity-related insulin resistance and hepatosteatosis.
作者信息
Alisi Anna, Panera Nadia, Nobili Valerio
机构信息
Liver Research Unit (A.A., N.P.) and Hepato-Metabolic Disease Unit (V.N.), Bambino Gesù Children's Hospital, Instituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy.
出版信息
Endocrinology. 2014 Feb;155(2):343-6. doi: 10.1210/en.2013-1828. Epub 2013 Nov 18.
PMID:24248463
Abstract
摘要
Zotero 插件